# Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Nov 21, 2022

Source: https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/a0c00f2b-71be-424c-b952-304a0e76ebce
Source feed: FDA_Inspections

> FDA inspection 1192256 of Centaur Pharmaceuticals Private Ltd., November 21, 2022. Classification: Official Action Indicated (OAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192256
- Company Name: Centaur Pharmaceuticals Private Ltd.
- Inspection Date: 2022-11-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1281041 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/9d1c7915-d7cc-4349-ae92-9a260f5df0f4)
- [FDA Inspection 1107995 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/dc970634-ace9-4877-84d2-d58de204ae0a)
- FDA Inspection 994501 - 2016-10-13
- FDA Inspection 914387 - 2015-02-05
- FDA Inspection 740701 - 2011-08-11

Company: https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/f96f4f92-5b20-4b5d-91d8-5b0dbe430494

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
